Correction: AMBIsome Therapy Induction OptimisatioN (AMBITION): High dose AmBisome for cryptococcal meningitis induction therapy in sub-Saharan Africa: Study protocol for a phase 3 randomised controlled non-inferiority trial (Trials (2018) 19 (649) DOI: 10.1186/s13063-018-3026-4)

David S. Lawrence; Nabila Youssouf; Síle F. Molloy; Alexandre Alanio; Melanie Alufandika; David R. Boulware; Timothée Boyer-Chammard; Tao Chen; Francoise Dromer; Admire Hlupeni; William Hope; Mina C. Hosseinipour; Cecilia Kanyama; Oliver Lortholary; Angela Loyse; David B. Meya; Mosepele Mosepele; Conrad Muzoora; Henry C. Mwandumba; Chiratidzo E. Ndhlovu; Louis Niessen; Charlotte Schutz; Katharine E. Stott; Duolao Wang; David G. Lalloo; Graeme Meintjes; Shabbar Jaffar; Thomas S. Harrison; Joseph N. Jarvis

doi:10.1186/s13063-018-3155-9

Correction: AMBIsome Therapy Induction OptimisatioN (AMBITION): High dose AmBisome for cryptococcal meningitis induction therapy in sub-Saharan Africa: Study protocol for a phase 3 randomised controlled non-inferiority trial (Trials (2018) 19 (649) DOI: 10.1186/s13063-018-3026-4)

David S. Lawrence, Nabila Youssouf, Síle F. Molloy, Alexandre Alanio, Melanie Alufandika, David R. Boulware, Timothée Boyer-Chammard, Tao Chen, Francoise Dromer, Admire Hlupeni, William Hope, Mina C. Hosseinipour, Cecilia Kanyama, Oliver Lortholary, Angela Loyse, David B. Meya, Mosepele Mosepele, Conrad Muzoora, Henry C. Mwandumba, Chiratidzo E. NdhlovuLouis Niessen, Charlotte Schutz, Katharine E. Stott, Duolao Wang, David G. Lalloo, Graeme Meintjes, Shabbar Jaffar, Thomas S. Harrison, Joseph N. Jarvis

Medicine - Infectious Disease and International

Research output: Contribution to journal › Comment/debate › peer-review

2 Scopus citations

Abstract

Following publication of the original article [1], we have been notified that one of the author names was listed incorrectly. Both incorrect and correct author names are presented below. The original publication has been corrected. Originally published name: Sile L F Molloy Correct name: Sile F Molloy.

Original language	English (US)
Article number	48
Journal	Trials
Volume	20
Issue number	1
DOIs	https://doi.org/10.1186/s13063-018-3155-9
State	Published - Jan 14 2019

Bibliographical note

Publisher Copyright:
© 2019 The Author(s).

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access

10.1186/s13063-018-3155-9

OpenUrl availability

Full text

Fingerprint

Dive into the research topics of 'Correction: AMBIsome Therapy Induction OptimisatioN (AMBITION): High dose AmBisome for cryptococcal meningitis induction therapy in sub-Saharan Africa: Study protocol for a phase 3 randomised controlled non-inferiority trial (Trials (2018) 19 (649) DOI: 10.1186/s13063-018-3026-4)'. Together they form a unique fingerprint.

Cite this

Lawrence, D. S., Youssouf, N., Molloy, S. F., Alanio, A., Alufandika, M., Boulware, D. R., Boyer-Chammard, T., Chen, T., Dromer, F., Hlupeni, A., Hope, W., Hosseinipour, M. C., Kanyama, C., Lortholary, O., Loyse, A., Meya, D. B., Mosepele, M., Muzoora, C., Mwandumba, H. C., ... Jarvis, J. N. (2019). Correction: AMBIsome Therapy Induction OptimisatioN (AMBITION): High dose AmBisome for cryptococcal meningitis induction therapy in sub-Saharan Africa: Study protocol for a phase 3 randomised controlled non-inferiority trial (Trials (2018) 19 (649) DOI: 10.1186/s13063-018-3026-4). Trials, 20(1), Article 48. https://doi.org/10.1186/s13063-018-3155-9

Correction: AMBIsome Therapy Induction OptimisatioN (AMBITION): High dose AmBisome for cryptococcal meningitis induction therapy in sub-Saharan Africa: Study protocol for a phase 3 randomised controlled non-inferiority trial (Trials (2018) 19 (649) DOI: 10.1186/s13063-018-3026-4). / Lawrence, David S.; Youssouf, Nabila; Molloy, Síle F. et al.
In: Trials, Vol. 20, No. 1, 48, 14.01.2019.

Research output: Contribution to journal › Comment/debate › peer-review

Lawrence, DS, Youssouf, N, Molloy, SF, Alanio, A, Alufandika, M, Boulware, DR, Boyer-Chammard, T, Chen, T, Dromer, F, Hlupeni, A, Hope, W, Hosseinipour, MC, Kanyama, C, Lortholary, O, Loyse, A, Meya, DB, Mosepele, M, Muzoora, C, Mwandumba, HC, Ndhlovu, CE, Niessen, L, Schutz, C, Stott, KE, Wang, D, Lalloo, DG, Meintjes, G, Jaffar, S, Harrison, TS & Jarvis, JN 2019, 'Correction: AMBIsome Therapy Induction OptimisatioN (AMBITION): High dose AmBisome for cryptococcal meningitis induction therapy in sub-Saharan Africa: Study protocol for a phase 3 randomised controlled non-inferiority trial (Trials (2018) 19 (649) DOI: 10.1186/s13063-018-3026-4)', Trials, vol. 20, no. 1, 48. https://doi.org/10.1186/s13063-018-3155-9

Lawrence DS, Youssouf N, Molloy SF, Alanio A, Alufandika M, Boulware DR et al. Correction: AMBIsome Therapy Induction OptimisatioN (AMBITION): High dose AmBisome for cryptococcal meningitis induction therapy in sub-Saharan Africa: Study protocol for a phase 3 randomised controlled non-inferiority trial (Trials (2018) 19 (649) DOI: 10.1186/s13063-018-3026-4). Trials. 2019 Jan 14;20(1):48. doi: 10.1186/s13063-018-3155-9

Lawrence, David S. ; Youssouf, Nabila ; Molloy, Síle F. et al. / Correction : AMBIsome Therapy Induction OptimisatioN (AMBITION): High dose AmBisome for cryptococcal meningitis induction therapy in sub-Saharan Africa: Study protocol for a phase 3 randomised controlled non-inferiority trial (Trials (2018) 19 (649) DOI: 10.1186/s13063-018-3026-4). In: Trials. 2019 ; Vol. 20, No. 1.

@article{803f17e4dcb74376a11c9d9204504150,

title = "Correction: AMBIsome Therapy Induction OptimisatioN (AMBITION): High dose AmBisome for cryptococcal meningitis induction therapy in sub-Saharan Africa: Study protocol for a phase 3 randomised controlled non-inferiority trial (Trials (2018) 19 (649) DOI: 10.1186/s13063-018-3026-4)",

abstract = "Following publication of the original article [1], we have been notified that one of the author names was listed incorrectly. Both incorrect and correct author names are presented below. The original publication has been corrected. Originally published name: Sile L F Molloy Correct name: Sile F Molloy.",

author = "Lawrence, {David S.} and Nabila Youssouf and Molloy, {S{\'i}le F.} and Alexandre Alanio and Melanie Alufandika and Boulware, {David R.} and Timoth{\'e}e Boyer-Chammard and Tao Chen and Francoise Dromer and Admire Hlupeni and William Hope and Hosseinipour, {Mina C.} and Cecilia Kanyama and Oliver Lortholary and Angela Loyse and Meya, {David B.} and Mosepele Mosepele and Conrad Muzoora and Mwandumba, {Henry C.} and Ndhlovu, {Chiratidzo E.} and Louis Niessen and Charlotte Schutz and Stott, {Katharine E.} and Duolao Wang and Lalloo, {David G.} and Graeme Meintjes and Shabbar Jaffar and Harrison, {Thomas S.} and Jarvis, {Joseph N.}",

note = "Publisher Copyright: {\textcopyright} 2019 The Author(s).",

year = "2019",

month = jan,

day = "14",

doi = "10.1186/s13063-018-3155-9",

language = "English (US)",

volume = "20",

journal = "Trials",

issn = "1745-6215",

publisher = "BioMed Central",

number = "1",

}

TY - JOUR

T1 - Correction

T2 - AMBIsome Therapy Induction OptimisatioN (AMBITION): High dose AmBisome for cryptococcal meningitis induction therapy in sub-Saharan Africa: Study protocol for a phase 3 randomised controlled non-inferiority trial (Trials (2018) 19 (649) DOI: 10.1186/s13063-018-3026-4)

AU - Lawrence, David S.

AU - Youssouf, Nabila

AU - Molloy, Síle F.

AU - Alanio, Alexandre

AU - Alufandika, Melanie

AU - Boulware, David R.

AU - Boyer-Chammard, Timothée

AU - Chen, Tao

AU - Dromer, Francoise

AU - Hlupeni, Admire

AU - Hope, William

AU - Hosseinipour, Mina C.

AU - Kanyama, Cecilia

AU - Lortholary, Oliver

AU - Loyse, Angela

AU - Meya, David B.

AU - Mosepele, Mosepele

AU - Muzoora, Conrad

AU - Mwandumba, Henry C.

AU - Ndhlovu, Chiratidzo E.

AU - Niessen, Louis

AU - Schutz, Charlotte

AU - Stott, Katharine E.

AU - Wang, Duolao

AU - Lalloo, David G.

AU - Meintjes, Graeme

AU - Jaffar, Shabbar

AU - Harrison, Thomas S.

AU - Jarvis, Joseph N.

PY - 2019/1/14

Y1 - 2019/1/14

N2 - Following publication of the original article [1], we have been notified that one of the author names was listed incorrectly. Both incorrect and correct author names are presented below. The original publication has been corrected. Originally published name: Sile L F Molloy Correct name: Sile F Molloy.

AB - Following publication of the original article [1], we have been notified that one of the author names was listed incorrectly. Both incorrect and correct author names are presented below. The original publication has been corrected. Originally published name: Sile L F Molloy Correct name: Sile F Molloy.

UR - http://www.scopus.com/inward/record.url?scp=85059985577&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059985577&partnerID=8YFLogxK

U2 - 10.1186/s13063-018-3155-9

DO - 10.1186/s13063-018-3155-9

M3 - Comment/debate

C2 - 30642386

AN - SCOPUS:85059985577

SN - 1745-6215

VL - 20

JO - Trials

JF - Trials

IS - 1

M1 - 48

ER -

Correction: AMBIsome Therapy Induction OptimisatioN (AMBITION): High dose AmBisome for cryptococcal meningitis induction therapy in sub-Saharan Africa: Study protocol for a phase 3 randomised controlled non-inferiority trial (Trials (2018) 19 (649) DOI: 10.1186/s13063-018-3026-4)

Abstract

Bibliographical note

UN SDGs

Access

OpenUrl availability

Other files and links

Fingerprint

Cite this